Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2012
10/02/2012US8278119 Detection method and detection reagent for autoimmune pancreatitis or fulminant type-1 diabetes
10/02/2012US8278099 Monoclonal antibody to human thrombopoietin
10/02/2012US8278067 Method for inhibiting hyperpigmentation
10/02/2012US8278042 Compositions and methods for the diagnosis and treatment of tumor
10/02/2012US8278037 N-acetylgalactosamine transferases and nucleic acids encoding the same
10/02/2012US8277810 Antagonist anti-CD40 antibodies
10/02/2012US8277808 Mucosal vascular addressins and uses thereof
10/02/2012US8277806 Use of trifunctional bispecific and trispecific antibodies for the treatment of malignant ascites
10/02/2012US8277805 Methods for treating or inhibiting thromboembolic disorders or for inhibiting coagulation
10/02/2012US8277804 Antagonists of IL-6 to prevent or treat thrombosis
10/02/2012US8277803 Cancerous disease modifying antibodies
10/02/2012CA2494223C Campylobacter glycans and glycopeptides
10/02/2012CA2492883C Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
10/02/2012CA2430135C Recombinant anti-cd30 antibodies and uses thereof
10/02/2012CA2417874C Use of ox-2 inhibitors for the treatment of cancer
10/02/2012CA2396534C Intrabodies with defined framework that is stable in a reducing environment and applications thereof
10/02/2012CA2332733C Signal peptides, nucleic acid molecules and methods for treatment of caries
10/02/2012CA2311297C Erythrovirus and its applications
10/02/2012CA2223269C Hepatocyte growth factor receptor antagonists and uses thereof
10/02/2012CA2133306C Amplification of human mdm2 gene in human tumors
09/2012
09/27/2012WO2012129514A1 Method and compositions for cellular immunotherapy
09/27/2012WO2012129227A1 Dendritic cells (dcs) targeting for tuberculosis (tb) vaccine
09/27/2012WO2012128508A2 Binding molecules capable of neutralizing the rabies virus, and uses thereof
09/27/2012WO2012128502A2 Composition for promoting vasculogenesis comprising pauf
09/27/2012WO2012128377A1 Composition for treatment and diagnosis of pancreatic cancer
09/27/2012WO2012128143A1 Monoclonal antibody specific to west nile viral structural protein and method for determining west nile viral infection using monoclonal antibody
09/27/2012WO2012128082A1 Anti-mouse aggrus monoclonal antibody
09/27/2012WO2012127063A1 SINGLE CHAIN ANTIGEN RECOGNIZING CONSTRUCTS (scARCs) STABILIZED BY THE INTRODUCTION OF NOVEL DISULFIDE BONDS
09/27/2012WO2012126879A1 Novel oprf/i fusion proteins, their preparation and use
09/27/2012WO2012126172A1 Peptides inhibiting adhesion of aspergillus fumigatus to cornea
09/27/2012WO2012068540A3 Neutralizing anti-ccl20 antibodies
09/27/2012WO2012059598A3 Methods of treating rheumatoid arthritis using il-17 antagonists
09/27/2012US20120245330 Neuropilin antagonists
09/27/2012US20120245093 Neuronal Viability Factor and Use Thereof
09/27/2012US20120245091 Polypeptide or fused protein thereof inhibiting the extravasation of white blood cells or the growth and/or metastasis of cancer cells
09/27/2012US20120244596 Anticalins
09/27/2012US20120244594 Immunoaffinity isolation of modified peptides from complex mixtures
09/27/2012US20120244578 Monomeric antibody fc
09/27/2012US20120244560 Monoclonal antibody against human hig-1 polypeptide
09/27/2012US20120244556 Markers for identifying tumor cells, methods and kit thereof
09/27/2012US20120244546 Antibodies specific to carbamazepine
09/27/2012US20120244544 Method for detecting microorganisms belonging to mycoplasma pneumoniae and/or mycoplasma genitalium
09/27/2012US20120244539 Method for screening of therapeutic agent for hyperlipemia
09/27/2012US20120244232 Black bear parathyroid hormone and methods of using black bear parathyroid hormone
09/27/2012US20120244189 Treatment of infections
09/27/2012US20120244184 Modified peptide vaccine derived from influenza m2
09/27/2012US20120244175 Tumor specific animal proteins
09/27/2012US20120244172 Conjudates of Pyrrolo[1,4]Benzodiazepine Dimers As Anticancer Agents
09/27/2012US20120244171 Cytotoxic benzodiazepine derivatives
09/27/2012US20120244169 Treatment for Radiation-Induced Disorders
09/27/2012US20120244168 Human antibodies that bind human il-12 and methods for producing
09/27/2012US20120244167 Antibodies to m-csf
09/27/2012US20120244166 Neutralizing antibodies to hiv-1 and their use
09/27/2012US20120244164 Biological materials related to c-met
09/27/2012US20120244162 Cross-species-specific bispecific binders
09/27/2012US20120244160 Identification of modulators of serine protease inhibitor kazal and their use as anti-cancer and anti-viral agents
09/27/2012US20120244159 Specific Antibodies To Amyloid Beta Peptide, Pharmaceutical Compositions And Methods Of Use Thereof
09/27/2012US20120244157 Use of tnf-alpha inhibitors for treating a nerve disorder mediated by nucleus pulposus
09/27/2012US20120244152 Novel antagonist antibodies and their fab fragments against gpvi and uses thereof
09/27/2012US20120244148 Anti-interferon-alpha antibodies
09/27/2012US20120244144 Pertussis antibodies and uses thereof
09/27/2012US20120244142 Antibody capable of recognizing hla class i
09/27/2012US20120244076 csPCNA Isoform Antibodies And Uses Thereof
09/27/2012US20120244069 Human monoclonal antibodies against cd25
09/27/2012CA2836007A1 Mouse anti-aggrus monoclonal antibodies
09/27/2012CA2830987A1 Dendritic cells (dcs) targeting for tuberculosis (tb) vaccine
09/27/2012CA2830953A1 Method and compositions for cellular immunotherapy
09/27/2012CA2830628A1 Composition for treatment and diagnosis of pancreatic cancer
09/26/2012EP2502999A2 Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
09/26/2012EP2502996A2 Anti-FGF23 antibody and pharmaceutical composition comprising the same
09/26/2012EP2502995A1 Pharmaceutical composition
09/26/2012EP2502993A1 Human artificial chromosome vector
09/26/2012EP2502992A1 Human artificial chromosome vector
09/26/2012EP2502938A2 Antibodies and immunoconjugates and uses therefor
09/26/2012EP2502937A2 Anti-CD 79b Antibodies And Immunoconjugates And Methods Of Use
09/26/2012EP2502936A1 Highly-functional mutant of humanized anti-egfr antibody variable region
09/26/2012EP2502935A2 Improved antibodies having altered effector function and methods for making the same
09/26/2012EP2502934A1 Single chain antigen recognizing constructs (scARCs) stabilized by the introduction of novel disulfide bonds
09/26/2012EP2502080A2 Multiplex immunoassays for hemoglobin, hemoglobin variants, and glycated forms
09/26/2012EP2501817A1 Common light chain mouse
09/26/2012EP2501814A1 Inhibitors of centrosomal clustering
09/26/2012EP2501810A1 Methods for producing antibody-producing cells that produce desired polypeptides
09/26/2012EP2501800A2 Human monoclonal antibodies to human nucleolin
09/26/2012EP2501724A2 Monoclonal antibodies and diagnostic uses thereof
09/26/2012EP2501723A1 Hepatitis b virus specific antibody and uses thereof
09/26/2012EP2501722A1 Method for producing t cell receptor-like monoclonal antibodies and uses thereof
09/26/2012EP2501721A2 Multivalent antibodies
09/26/2012EP2501407A1 Anti-orai1 antigen binding proteins and uses thereof
09/26/2012CN1980696B Method and system to remove soluble TNFR1, TNFR2, and IL2 in patients
09/26/2012CN1942483B Anti-P-selectin antibodies
09/26/2012CN1909921B Compositions for reducing bacterial carriage and cns invasion and methods of using same
09/26/2012CN102695956A Assays for detecting antibodies specific to therapeutic anti-IgE antibodies and their use in anaphylaxis
09/26/2012CN102695724A Antibodies or fragments thereof directed against a staphylococcus aureus epitope of ISAA or ISAB
09/26/2012CN102695722A Antibodies and epitopes specific to misfolded prion protein
09/26/2012CN102690799A Enzymes having dehalogenase activity and methods of use thereof
09/26/2012CN102690789A Hybridoma cell strain secreting tetanus exotoxin monoclonal antibody, monoclonal antibody prepared by same, Fab antibody and application
09/26/2012CN102690788A Zearalenone anti-idiotypic antibody, preparation method thereof, and application thereof
09/26/2012CN102690787A Hybridoma cells capable of secreting an anti human [beta]-actin protein monoclonal antibody and preparation method thereof
09/26/2012CN102690351A Preparation method of plasmodium vivax aldolase protein monoclonal antibody
09/26/2012CN102690350A Anti-il-22ra antibodies and binding partners and methods of using in inflammation
1 ... 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 ... 1494